Tci Gene (ROCO:6879) Change In Receivables : NT$-29.4 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Change In Receivables?

Tci Gene's change in receivables for the quarter that ended in Dec. 2023 was NT$-36.1 Mil. It means Tci Gene's Accounts Receivable increased by NT$36.1 Mil from Jun. 2023 to Dec. 2023 .

Tci Gene's change in receivables for the fiscal year that ended in Dec. 2023 was NT$-29.4 Mil. It means Tci Gene's Accounts Receivable increased by NT$29.4 Mil from Dec. 2022 to Dec. 2023 .

Tci Gene's Accounts Receivable for the quarter that ended in Dec. 2023 was NT$102.6 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Tci Gene's Days Sales Outstanding for the six months ended in Dec. 2023 was 101.76.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Tci Gene's liquidation value for the six months ended in Dec. 2023 was NT$848.5 Mil.

Tci Gene Change In Receivables Historical Data

The historical data trend for Tci Gene's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Change In Receivables Chart

Tci Gene Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

31.11

-11.02

-72.28

43.36

-29.39

Tci Gene Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial				-31.29	-22.53	65.89	6.71	-36.10

Tci Gene Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-29.4 Mil.

Tci Gene (ROCO:6879) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Tci Gene's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	102.59	/	183.992	*	91
=	101.76

2. In Ben Graham's calculation of liquidation value, Tci Gene's accounts receivable are only considered to be worth 75% of book value:

Tci Gene's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	899.646	-	155.548	+	0.75 * 102.59	+	0.5 * 54.847
=	848.5

Tci Gene Change In Receivables Related Terms

Thank you for viewing the detailed overview of Tci Gene's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Tci Gene (ROCO:6879) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN

Website

https://www.genext.me

Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines